T. Rowe Price (RVTY) discloses 10.1M-share, 9.0% stake in Revvity
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting beneficial ownership of 10,097,663 shares of Revvity Inc. common stock, representing 9.0% of the class. The filing shows sole voting power for 10,019,315 shares and sole dispositive power for 10,097,663 shares. The amendment is signed by Ellen York, Vice President, on 05/15/2026.
Positive
- None.
Negative
- None.
Insights
T. Rowe Price holds a single-digit, large institutional stake in Revvity (9.0%).
The filing reports 10,097,663 shares beneficially owned and discloses sole voting power for 10,019,315 shares. This positions T. Rowe Price among material passive holders and is typical for an investment manager filing a Schedule 13G/A.
Key dependencies are voting coordination and any future amendments; subsequent filings would show if the position rises above passive thresholds or changes voting stance.
The amendment clarifies voting and dispositive authority without indicating active control.
The form lists exact voting and dispositive counts rather than proposing changes to board composition or corporate action. The signer affirms the filing but includes a statement denying beneficial ownership, a common disclosure when an investment manager reports on behalf of client accounts.
Watch for any later Schedule 13D/13G amendments that would signal an active intent; timing not specified in the excerpt.
Key Figures
Key Terms
Beneficially owned regulatory
Sole dispositive power regulatory
Schedule 13G/A regulatory
CUSIP other
AI-generated analysis. How Rhea-AI works. Not financial advice.